Metastasis remains the primary challenge to reducing cancer deaths worldwide, says Memorial Sloan Kettering Cancer Center ...

Raman is also a member of the Johns Hopkins Kimmel Cancer Center. “We first had to determine whether DDX3 was expressed in ...

Breast cancer can spread to your bones, lungs, liver, and brain, among other parts of your body. In a 2020 study of 414,528 people with breast cancer, 5,185 people (1.25%) developed metastatic ...

In this excerpt from "Too Young for Cancer," Katie Coleman describes receiving her cancer diagnosis after years of having her ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously ...

More information: Paul T. Winnard et al, Targeting RNA helicase DDX3X with a small molecule inhibitor for breast cancer bone ...

Their findings hold promise for advancing the development of preclinical tools to predict breast cancer bone metastasis. Researchers from Tampere University, Finland, and Izmir Institute of ...

Future Oncol. 2010;6(1):55-74. Stimulates proliferation, migration and invasiveness of breast cancer cells SPRYCEL Phase III trials recruiting for CML Phase I/II (+ZA) recruit Important for proper ...

Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...

After determining that breast cancer bone metastasis cells had high levels of DDX3, the research team turned to mice to test if RK-33 had any effect on the DDX3 protein and function of the cancer ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis).RK-33 was previously ...